<html><head>
<meta http-equiv="Content-Type" content="text/html; charset=utf-8">
</head><body>
<span style="position:absolute; border: gray 1px solid; left:0px; top:50px; width:612px; height:792px;"></span>
<div style="position:absolute; top:50px;"><a name="1">Page 1</a></div>
<div style="position:absolute; border: textbox 1px solid; writing-mode:lr-tb; left:56px; top:108px; width:501px; height:656px;"><span style="font-family: Arial,Bold; font-size:11px">Short Oral Abstract 9 - Effect of oat β-glucan on markers of lipid control: a 
<br>systematic review and meta-analysis</span><span style="font-family: Arial; font-size:11px">  
<br></span><span style="font-family: Arial,Bold; font-size:11px">(Thanh Ho, Canada) 
<br></span><span style="font-family: Arial,Italic; font-size:11px"> 
<br></span><span style="font-family: Arial,Italic; font-size:10px">Thanh Ho</span><span style="font-family: Arial,Italic; font-size:6px">1,3</span><span style="font-family: Arial,Italic; font-size:10px">*, John Sievenpiper</span><span style="font-family: Arial,Italic; font-size:6px">1,2,4</span><span style="font-family: Arial,Italic; font-size:10px">, Andreea Zurbau</span><span style="font-family: Arial,Italic; font-size:6px">1,3</span><span style="font-family: Arial,Italic; font-size:10px">, Sonia Mejia Blanco</span><span style="font-family: Arial,Italic; font-size:6px">1,3,4</span><span style="font-family: Arial,Italic; font-size:10px">, Russell de Souza</span><span style="font-family: Arial,Italic; font-size:6px">1,4,5</span><span style="font-family: Arial,Italic; font-size:10px">, 
<br>Elena Jovanovski</span><span style="font-family: Arial,Italic; font-size:6px">1,3</span><span style="font-family: Arial,Italic; font-size:10px">, Alexandra Jenkins</span><span style="font-family: Arial,Italic; font-size:6px">1</span><span style="font-family: Arial,Italic; font-size:10px">, David JA Jenkins</span><span style="font-family: Arial,Italic; font-size:6px">1,3,4</span><span style="font-family: Arial,Italic; font-size:10px">, Vladimir Vuksan</span><span style="font-family: Arial,Italic; font-size:6px">1,2,3 
<br></span><span style="font-family: Arial,Italic; font-size:10px"> </span><span style="font-family: Arial,Italic; font-size:6px">1</span><span style="font-family: Arial,Italic; font-size:10px">Clinical Nutrition and Risk Factor Modification Centre, St. Michael’s Hospital, 193 Yonge Street, 
<br>Toronto, Ontario, Canada 
<br></span><span style="font-family: Arial,Italic; font-size:6px">2</span><span style="font-family: Arial,Italic; font-size:10px">Li Ka Shing Knowledge Institute and Keenan Research Centre, St. Michael’s Hospital, 209 Victoria 
<br>Street, Toronto, Ontario, Canada 
<br></span><span style="font-family: Arial,Italic; font-size:6px">3</span><span style="font-family: Arial,Italic; font-size:10px">Department of Nutritional Sciences, Faculty of Medicine, University of Toronto, 150 College Street, 
<br>Toronto, Ontario, Canada 
<br></span><span style="font-family: Arial,Italic; font-size:6px">4</span><span style="font-family: Arial,Italic; font-size:10px">Toronto 3D Knowledge Synthesis and Clinical Trials Unit, St. Michael’s Hospital, 61 Queen Street 
<br>East, Toronto, Ontario, Canada 
<br></span><span style="font-family: Arial,Italic; font-size:6px">5</span><span style="font-family: Arial,Italic; font-size:10px">Department of Clinical Epidemiology &amp; Biostatistics, Faculty of Health Sciences, McMaster University, 
<br>Hamilton, Ontario, Canada 
<br> 
<br></span><span style="font-family: Arial,Bold; font-size:10px">Objective: </span><span style="font-family: Arial; font-size:10px">Low-density lipoprotein cholesterol (LDL-C) lowering has been the focused of 
<br>cardiovascular disease (CVD) prevention, however, despite highly effective statin therapy for LDL-C 
<br>lowering, residual risk remains. Therefore, alternative lipid targets, ie. apolipoprotein B (apoB) and 
<br>non-high-density lipoprotein cholesterol (non-HDL-C), have been implemented to assess residual risk. 
<br>β-glucan, the main soluble fibre found in oats, is often ascribed with being the main active component 
<br>responsible for the cholesterol-lowering effect. Given the established LDL-C lowering effect of oat β-
<br>glucan (OβG), this systematic review and meta-analysis seeks to update the evidence in the context of 
<br>OβG and LDL-C and additionally, to summarize and quantify the effect of OβG on the alternate lipid 
<br>targets, apoB and non-HDL-C, for the first time.   
<br></span><span style="font-family: Arial,Bold; font-size:10px">Methods: </span><span style="font-family: Arial; font-size:10px">MEDLINE, Embase, CINAHL, and the Cochrane Central Register of Controlled Trials were 
<br>searched. Randomized controlled trials ≥3 weeks reporting OβG consumption on LDL-C, apoB and/or 
<br>non-HDL-C. Two independent reviewer’s extracted relevant data and assessed study quality and risk 
<br>of bias. Data were pooled using the generic inverse variance method with random effects models and 
<br>expressed as mean differences with 95% confidence intervals (CI’s). Heterogeneity was assessed 
<br>(Cochran Q-statistic) and quantified (I</span><span style="font-family: Arial; font-size:6px">2</span><span style="font-family: Arial; font-size:10px">). 
<br></span><span style="font-family: Arial,Bold; font-size:10px">Results: </span><span style="font-family: Arial; font-size:10px">51 trials were included (n=3420). A median dose of 3.6 g/d significantly lowered LDL-C 
<br>(MD=-0.23 [95% CI: -0.33, -0.14]; p&lt;0.00001), apoB (MD=-0.05 [95% CI: -0.08, -0.02]; p&lt;0.00001) 
<br>and non-HDL-C (MD=-0.24 [95% CI: -0.28, -0.20]; p&lt;0.00001) compared with control diets.  
<br></span><span style="font-family: Arial,Bold; font-size:10px">Conclusion: </span><span style="font-family: Arial; font-size:10px">Pooled analyses confirm an LDL-C lowering effect with consumption of OβG. It 
<br>additionally implicates a beneficial effect on alternate lipid targets, apoB and non-HDL-C. Though, the 
<br>results may be limited by the short duration, poor quality of the majority of the trials, and significant 
<br></span><span style="font-family: Arial; font-size:10px">between-study heterogeneity. 
<br></span><span style="font-family: Arial,Bold; font-size:10px">Trial Registration: </span><span style="font-family: Arial; font-size:10px">ClinicalTrials.gov NCT02068248 
<br></span><span style="font-family: Arial,Bold; font-size:10px">Funding: </span><span style="font-family: Arial; font-size:10px">N/A 
<br></span><span style="font-family: Arial; font-size:11px"> 
<br> 
<br></span><span style="font-family: Arial,Bold; font-size:11px">Short Oral Abstract 10 - The Effects of Maternal Diet on Glycemic Control: A 
<br>Systematic Review and Network Meta-Analysis</span><span style="font-family: Arial; font-size:11px">  
<br></span><span style="font-family: Arial,Bold; font-size:11px">(Vanessa Ha, Canada) 
<br></span><span style="font-family: Arial; font-size:11px"> 
<br></span><span style="font-family: Arial,Italic; font-size:10px">Vanessa Ha</span><span style="font-family: Arial,Italic; font-size:6px">1,4*</span><span style="font-family: Arial,Italic; font-size:10px">, Ashley J Bonner</span><span style="font-family: Arial,Italic; font-size:6px">1</span><span style="font-family: Arial,Italic; font-size:10px">, Jaynendr K Jadoo, Joseph Beyene</span><span style="font-family: Arial,Italic; font-size:6px">1,3</span><span style="font-family: Arial,Italic; font-size:10px">, Sonia Anand</span><span style="font-family: Arial,Italic; font-size:6px">1,2</span><span style="font-family: Arial,Italic; font-size:10px">, Russell J de 
<br>Souza</span><span style="font-family: Arial,Italic; font-size:6px">1,4 
<br>1</span><span style="font-family: Arial,Italic; font-size:10px">Department  of  Clinical  Epidemiology  &amp;  Biostatistics,  </span><span style="font-family: Arial,Italic; font-size:6px">2</span><span style="font-family: Arial,Italic; font-size:10px">Department  of  Medicine,  Faculty  of  Health 
<br>Sciences,  McMaster  University,  Hamilton,  Ontario,  CANADA;  </span><span style="font-family: Arial,Italic; font-size:6px">3</span><span style="font-family: Arial,Italic; font-size:10px">Health  Sciences  Program,  Research 
<br></span></div><div style="position:absolute; border: textbox 1px solid; writing-mode:lr-tb; left:56px; top:781px; width:13px; height:24px;"><span style="font-family: ABCDEE+Calibri; font-size:11px">59 
<br> 
<br></span></div><div style="position:absolute; top:0px;">Page: <a href="#1">1</a></div>
</body></html>
